0.44 0 (0%) | 04-04 16:00 | |||||||||||||
|
|
Short term | ||||
Mid term | ||||
Targets | 6-month : | 0.56 | 1-year : | 0.65 |
Resists | First : | 0.47 | Second : | 0.56 |
Pivot price | 0.43 | |||
Supports | First : | 0.36 | Second : | 0.29 |
MAs | MA(5) : | 0.43 | MA(20) : | 0.4 |
MA(100) : | 0.45 | MA(250) : | 0.7 | |
MACD | MACD : | 0 | Signal : | 0 |
%K %D | K(14,3) : | 77.2 | D(3) : | 77.5 |
RSI | RSI(14): 63.1 | |||
52-week | High : | 1.77 | Low : | 0.27 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ BRCN ] has closed below upper band by 43.3%. Bollinger Bands are 28.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
If tomorrow: | Open lower | Open higher |
High: | 0.48 - 0.48 | 0.48 - 0.48 |
Low: | 0.43 - 0.44 | 0.44 - 0.44 |
Close: | 0.44 - 0.44 | 0.44 - 0.44 |
Burcon NutraScience Corporation, together with its subsidiaries, develops plant proteins and ingredients for use in the food and beverage industries in Canada. The company's products include Peazazz, a pea protein for use in dairy alternatives, ready-to-drink beverages, dry blended beverages, bars, baked goods, and meat substitute products; and Peazac and Peazac 850, a pea protein for plant-based meat alternative products, ready-to-mix powders, ready-to-mix beverages, dairy alternatives, and nutrition bars, as well as other applications requiring the most neutral flavor and moderate viscosity. It provides Puratein, a canola protein isolate for use in meat alternatives, such as burgers, sausages, and nutrition bars; Supertein, a canola protein that is a light-colored powder for use in non-dairy frozen desserts, egg alternative, plant-based marshmallows and ready-to-mix beverages, whipped toppings, and plant-based bars; and Nutratein, a canola protein comprising a mixture of globulin and albumin proteins for use in meat and egg alternatives, and other plant-based functional foods. In addition, the company offers Nutratein-PS and Nutratein-TZ, a blend of Peazac pea protein; and CLARISOY, a soy protein for use in sports nutrition beverages, citrus-based drinks, fruit-flavored beverages, lemonades, powdered beverage mixes, and other foods and nutritional products. Further, it provides MeritPro, a nutritional protein blend, including allergen-free, gluten-free, non-dairy, non-GMO, and vegan. The company was formerly known as Burcon Capital Corp. and changed its name to Burcon NutraScience Corporation in October 1999. The company was incorporated in 1998 and is headquartered in Vancouver, Canada.
Thu, 12 May 2022
Burcon (BRCN) – Partner Bunge's Growth Capex Within Alternative Proteins Bodes Well - Seeking Alpha
Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
Exchange:
NASDAQ
|
|
Sector:
Consumer Defensive
|
|
Industry:
Packaged Foods
|
|
Shares Out | 0 (M) |
Shares Float | 109 (M) |
Held by Insiders | 8.094e+007 (%) |
Held by Institutions | 23.6 (%) |
Shares Short | 135 (K) |
Shares Short P.Month | 0 (K) |
EPS | -7.58e+006 |
EPS Est Next Qtrly | 0 |
EPS Est This Year | 0 |
EPS Est Next Year | 0 |
Book Value (p.s.) | 0 |
Profit Margin | 0 % |
Operating Margin | -4 % |
Return on Assets (ttm) | 512.5 % |
Return on Equity (ttm) | -14.5 % |
Qtrly Rev. Growth | 171470 % |
Gross Profit (p.s.) | -31.41 |
Sales Per Share | -14.46 |
EBITDA (p.s.) | -581818 |
Qtrly Earnings Growth | -0.1 % |
Operating Cash Flow | 0 (M) |
Levered Free Cash Flow | -6 (M) |
PE Ratio | -0.01 |
PEG Ratio | 0 |
Price to Book value | 0 |
Price to Sales | -0.04 |
Price to Cash Flow | 3.22 |
Dividend | 0 |
Forward Dividend | 127140 |
Dividend Yield | 0% |
Dividend Pay Date | Invalid DateTime. |
Ex-Dividend Date | Invalid DateTime. |